Therefore, to examine whether hepatic mTOR/S6K activation leads to hypertriglyceridemia, we expressed Rheb, which reportedly activates mTORC1 (refs 9, 10, 31). The gene discussed is RHEB; the disease is hypertriglyceridemia.